Lineage Cell Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2011 | — | $28.6M | $22.2M |
| FY2012 | — | $9.6M | $4.4M |
| FY2013 | — | $14.8M | $5.5M |
| FY2014 | — | $36.5M | $29.5M |
| FY2015 | — | $25.8M | $42.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2011 | — | $28.6M | $22.2M |
| FY2012 | — | $9.6M | $4.4M |
| FY2013 | — | $14.8M | $5.5M |
| FY2014 | — | $36.5M | $29.5M |
| FY2015 | — | $25.8M | $42.2M |